Study of CM313 (SC) Injection in Subjects With Primary Immune Thrombocytopenia (ITP)
Clinical trial NCT06594146 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06594146
- Sponsor
- Keymed Biosciences Co.Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-11
- Primary completion
- 2025-12-30
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.